Wei Lin
Chief Tech/Sci/R&D Officer at REVOLUTION MEDICINES, INC.
Net worth: 3 M $ as of 31/03/2024
Profile
Wei Lin is currently an Independent Director at 2seventy Bio, Inc. and the Chief Medical Officer at Revolution Medicines, Inc. Previously, he held the position of Senior Vice President-Clinical Development at Nektar Therapeutics from 2018 to 2021.
From 2006 to 2009, he served as the Site Head-Oncology Product Development at Roche (China) Co. Ltd.
Dr. Lin was also the Chief Medical Officer at Erasca, Inc. from 2021 to 2023.
Additionally, he held a position at Genentech, Inc. as the Head-Neck Cancers.
Dr. Lin completed his undergraduate studies at Haverford College and obtained his doctorate degree from Harvard Medical School in 2004.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/03/2024 | 74,400 ( 0.05% ) | 2 M $ | 31/03/2024 | |
2SEVENTY BIO, INC.
0.04% | 13/06/2023 | 20,800 ( 0.04% ) | 111 280 $ | 31/03/2024 |
Wei Lin active positions
| Companies | Position | Start |
|---|---|---|
| 2SEVENTY BIO, INC. | Director/Board Member | 07/03/2023 |
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 01/04/2023 |
Former positions of Wei Lin
| Companies | Position | End |
|---|---|---|
| ERASCA, INC. | Chief Tech/Sci/R&D Officer | 10/04/2023 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 05/01/2021 |
| Roche (China) Co. Ltd. | Corporate Officer/Principal | 01/01/2009 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Wei Lin
| Haverford College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Roche (China) Co. Ltd. |
- Stock Market
- Insiders
- Wei Lin
